Arrowstreet Capital, Limited Partnership Takeda Pharmaceutical CO LTD Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 4,216,373 shares of TAK stock, worth $58.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,216,373
Previous 4,635,392
9.04%
Holding current value
$58.6 Million
Previous $65.9 Million
15.25%
% of portfolio
0.05%
Previous 0.05%
Shares
23 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$183 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$77.9 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$64.3 Million0.01% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$45 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$42.8 Million0.06% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...